DE69737972D1 - Diagnostische und therapeutische verfahren in zusammenhang mit der regulation der energiemobilisation durch ob-protein und ob-antikörper - Google Patents

Diagnostische und therapeutische verfahren in zusammenhang mit der regulation der energiemobilisation durch ob-protein und ob-antikörper

Info

Publication number
DE69737972D1
DE69737972D1 DE69737972T DE69737972T DE69737972D1 DE 69737972 D1 DE69737972 D1 DE 69737972D1 DE 69737972 T DE69737972 T DE 69737972T DE 69737972 T DE69737972 T DE 69737972T DE 69737972 D1 DE69737972 D1 DE 69737972D1
Authority
DE
Germany
Prior art keywords
protein
emobilization
diagnostic
antibody
regulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69737972T
Other languages
English (en)
Other versions
DE69737972T2 (de
Inventor
Lili Feng
Sizhong Chen
Yiyang Xia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Application granted granted Critical
Publication of DE69737972D1 publication Critical patent/DE69737972D1/de
Publication of DE69737972T2 publication Critical patent/DE69737972T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69737972T 1996-06-04 1997-06-04 Diagnostische und therapeutische verfahren in zusammenhang mit der regulation der energiemobilisation durch ob-protein und ob-antikörper Expired - Fee Related DE69737972T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1897296P 1996-06-04 1996-06-04
US18972P 1996-06-04
PCT/US1997/009684 WO1997046249A1 (en) 1996-06-04 1997-06-04 Diagnostic and therapeutic methods related to regulating energy mobilization with ob protein and ob antibodies

Publications (2)

Publication Number Publication Date
DE69737972D1 true DE69737972D1 (de) 2007-09-13
DE69737972T2 DE69737972T2 (de) 2008-04-10

Family

ID=21790709

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69737972T Expired - Fee Related DE69737972T2 (de) 1996-06-04 1997-06-04 Diagnostische und therapeutische verfahren in zusammenhang mit der regulation der energiemobilisation durch ob-protein und ob-antikörper

Country Status (8)

Country Link
EP (1) EP0929310B1 (de)
AT (1) ATE368471T1 (de)
AU (1) AU743161B2 (de)
CA (1) CA2257140A1 (de)
DE (1) DE69737972T2 (de)
DK (1) DK0929310T3 (de)
ES (1) ES2289759T3 (de)
WO (1) WO1997046249A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017371382A1 (en) * 2016-12-06 2019-06-13 St Vincent's Hospital Sydney Limited Treatment of obesity and eating disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3329895A (en) * 1994-08-17 1996-03-07 Rockefeller University, The Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
WO1996035787A1 (en) * 1995-05-08 1996-11-14 Chiron Corporation Nucleic acids for treating obesity

Also Published As

Publication number Publication date
CA2257140A1 (en) 1997-12-11
ES2289759T3 (es) 2008-02-01
DE69737972T2 (de) 2008-04-10
EP0929310A1 (de) 1999-07-21
ATE368471T1 (de) 2007-08-15
WO1997046249A1 (en) 1997-12-11
DK0929310T3 (da) 2007-12-10
AU743161B2 (en) 2002-01-17
EP0929310A4 (de) 2002-01-30
AU3377197A (en) 1998-01-05
EP0929310B1 (de) 2007-08-01

Similar Documents

Publication Publication Date Title
Ansel et al. Human keratinocytes are a major source of cutaneous platelet-derived growth factor.
Haque et al. Interferon gamma (IFN‐γ) may reverse oral submucous fibrosis
DE69930872T8 (de) Antikörper gegen verkürzten vegf-d und deren verwendungen
BR0008161A (pt) Uso de uma composição terapêutica para tratamento de uma célula tumoral, composição terapêutica, e kit para tratamento de uma célula tumoral
DE69738868D1 (de) Odieren, und deren verwendung zur vorbeugung und zum nachweis von krebs
BR9509434A (pt) Agente de aglutinação uso do mesmo composição farmacêutica e processo de tratamento de uma doença inflamatória autoimune ou alérgica
CY1111863T1 (el) Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
UA87979C2 (ru) Человеческое моноклональное антитело, которое нейтрализует моноцитарный хемоатрактантный белок (мср-1)
DK0920509T3 (da) Polypeptider, der er i stand til at danne antigenbindende strukturer med specificitet for Rhesus D-antigener, DNA, der koder herfor, samt fremgangsmåde til fremstilling heraf og anvendelse heraf
DE69719754D1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
TR199901636T2 (xx) �mm�nolojik hastal�klar�n tedavisi i�in terap�tik maddeler olarak ��z�n�r lenfotoksin-beta resept�rleri, anti-lenfotoksin resept�r� antikorlar� ve anti-lenfotoksin ba�� antikorlar�.
TR200102877T2 (tr) İmmünoglobulinin kendi yüksek afinite reseptörüne bağlanmasını inhibe eden antikorlara karşı anti-idiotipik antikorlar.
ATE449847T1 (de) Hepatitis c rezeptorprotein cd81
DE69115917T2 (de) Humane gammainterferonantagonisten
DE69737972D1 (de) Diagnostische und therapeutische verfahren in zusammenhang mit der regulation der energiemobilisation durch ob-protein und ob-antikörper
ATE234862T1 (de) Glycoproteine mit lipidmobilisierenden eigenschaften und deren therapeutische verwendungen
Hedberg et al. The expression of HLA‐DR on keratinocytes in oral lichen planus
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
FI961584A (fi) C-reaktiivisista proteiinifragmenteista johdetut oligopeptidit
PL400309A1 (pl) Kwasy nukleinowe, proteiny oraz przeciwciala BTL-II
DE69729857D1 (de) An menschliches wachstumshormon (hgh) bindende monoklonale antikörper
WO2000017363A3 (en) Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses
Thomas et al. Role of substance P in inflammation in dental pulp

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee